Status:
COMPLETED
Antimalarial and Covid 19 in Rheumatoid Arthritis
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
20-70 years
Brief Summary
The antimalarial agent hydroxychloroquine(HCQ) have been used widely used for the treatment of rheumatoid arthritis and systemic lupus erythematosus. These compounds lead to improvement of clinical an...
Detailed Description
The antimalarial agent hydroxychloroquine(HCQ) have been used widely used for the treatment of rheumatoid arthritis and systemic lupus erythematosus.(1) . These compounds lead to improvement of clinic...
Eligibility Criteria
Inclusion
- rheumatoid arthritis recieving hydroxychloroquine chest infection
Exclusion
- patients not used hydroxychloroquine
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04389320
Start Date
March 15 2020
End Date
May 1 2020
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manal Hassanien
Asyut, Yes, Egypt, 7111